<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Database (Oxford)</journal-id>
    <journal-id journal-id-type="iso-abbrev">Database (Oxford)</journal-id>
    <journal-id journal-id-type="publisher-id">databa</journal-id>
    <journal-title-group>
      <journal-title>Database: The Journal of Biological Databases and Curation</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1758-0463</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
      <publisher-loc>UK</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">8725190</article-id>
    <article-id pub-id-type="pmid">34907423</article-id>
    <article-id pub-id-type="doi">10.1093/database/baab079</article-id>
    <article-id pub-id-type="publisher-id">baab079</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Original Article</subject>
      </subj-group>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI00960</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>iCAV: an integrative database of cancer-associated viruses</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Liu</surname>
          <given-names>Bo</given-names>
        </name>
        <xref rid="FT0001" ref-type="author-notes"/>
        <aff><institution content-type="department">School of Life Sciences, Zhengzhou
University</institution>, Zhengzhou 450001, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zhang</surname>
          <given-names>Qingfeng</given-names>
        </name>
        <xref rid="FT0001" ref-type="author-notes"/>
        <aff><institution content-type="department">State Key Laboratory of Oncology in South China,
Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer
Center</institution>, Guangzhou 510060, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Wang</surname>
          <given-names>Jingou</given-names>
        </name>
        <aff><institution content-type="department">School of Life Sciences, Zhengzhou
University</institution>, Zhengzhou 450001, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Cao</surname>
          <given-names>Shumin</given-names>
        </name>
        <aff><institution content-type="department">School of Life Sciences, Zhengzhou
University</institution>, Zhengzhou 450001, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zhou</surname>
          <given-names>Zhiyuan</given-names>
        </name>
        <aff><institution content-type="department">School of Life Sciences, Zhengzhou
University</institution>, Zhengzhou 450001, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-9698-0610</contrib-id>
        <name>
          <surname>Liu</surname>
          <given-names>Ze-Xian</given-names>
        </name>
        <!--liuzx@sysucc.org.cn-->
        <xref rid="COR0001" ref-type="corresp"/>
        <aff><institution content-type="department">State Key Laboratory of Oncology in South China,
Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer
Center</institution>, Guangzhou 510060, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-6684-317X</contrib-id>
        <name>
          <surname>Cheng</surname>
          <given-names>Han</given-names>
        </name>
        <!--chenghan@zzu.edu.cn-->
        <xref rid="COR0001" ref-type="corresp"/>
        <aff><institution content-type="department">School of Life Sciences, Zhengzhou
University</institution>, Zhengzhou 450001, <country country="CN">China</country></aff>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="COR0001">*Correspondence may also be addressed to Han Cheng. Tel: +86 0371 6778
0989; Fax: +86 0371 6778 0989; E-mail: <email xlink:href="chenghan@zzu.edu.cn">chenghan@zzu.edu.cn</email> and Ze-Xian Liu: Tel: +86
20 8734 2522; Fax: +86 20 8734 2522; E-mail: <email xlink:href="liuzx@sysucc.org.cn">liuzx@sysucc.org.cn</email></corresp>
      <fn id="FT0001">
        <label>
          <sup>#</sup>
        </label>
        <p>Bo Liu, Qingfeng Zhang contributed equally to this work.</p>
      </fn>
    </author-notes>
    <pub-date pub-type="collection">
      <year>2021</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2021-12-15">
      <day>15</day>
      <month>12</month>
      <year>2021</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>15</day>
      <month>12</month>
      <year>2021</year>
    </pub-date>
    <volume>2021</volume>
    <elocation-id>baab079</elocation-id>
    <history>
      <date date-type="received">
        <day>14</day>
        <month>7</month>
        <year>2021</year>
      </date>
      <date date-type="rev-recd">
        <day>12</day>
        <month>11</month>
        <year>2021</year>
      </date>
      <date date-type="accepted">
        <day>07</day>
        <month>12</month>
        <year>2021</year>
      </date>
      <date date-type="editorial-decision">
        <day>22</day>
        <month>11</month>
        <year>2021</year>
      </date>
      <date date-type="corrected-typeset">
        <day>15</day>
        <month>12</month>
        <year>2021</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2021. Published by Oxford University
Press.</copyright-statement>
      <copyright-year>2021</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted
reuse, distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="baab079.pdf"/>
    <abstract>
      <title>Abstract</title>
      <p>To date, various studies have found that the occurrence of cancer may be related to viral
infections. Therefore, it is important to explore the relationship between viruses and
diseases. The International Agency for Research on Cancer has defined six types of viruses
as Class 1 human carcinogens, including Epstein–Barr virus, hepatitis C virus, hepatitis B
virus, human T-cell lymphotropic virus, human herpesvirus 8 and human papillomavirus,
while Merkel cell polyomavirus is classified as ‘probably carcinogenic to humans’ (Group
2A). Therefore, in-depth research on these viruses will help clarify their relationship
with diseases, and substantial efforts have been made to sequence their genomes. However,
there is no complete database documenting these cancer-associated viruses, and researchers
are not able to easily access and retrieve the published genomes. In this study, we
developed iCAV, a database that integrates the genomes of cancer-related viruses and the
corresponding phenotypes. We collected a total of 18 649 genome sequences from seven human
disease-related viruses, and each virus was further classified by the associated disease,
sample and country. iCAV is a comprehensive resource of cancer-associated viruses that
provides browse and download functions for viral genomes.</p>
      <p><bold>Database URL</bold>: <ext-link xlink:href="http://icav.omicsbio.info/" ext-link-type="uri">http://icav.omicsbio.info/</ext-link></p>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Natural Science Foundation of China</institution>
            <institution-id institution-id-type="DOI">10.13039/501100001809</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>81972239 and 91953123 to ZX.L., 31601067 to H.C.</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Fostering Fund of Fundamental Research for Young Teachers of Zhengzhou
University</institution>
          </institution-wrap>
        </funding-source>
        <award-id>JC21343016 to H.C.</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Program for Guangdong Introducing Innovative and Entrepreneurial
Teams</institution>
          </institution-wrap>
        </funding-source>
        <award-id>2017ZT07S096 to ZX.L.</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Guangdong Esophageal Cancer Institute Science and Technology
Program</institution>
          </institution-wrap>
        </funding-source>
        <award-id>M201911 to Z.-X.L.</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Tip-Top Scientific and Technical Innovative Youth Talents of Guangdong
special support program</institution>
          </institution-wrap>
        </funding-source>
        <award-id>2019TQ05Y351 to ZX.L.</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="5"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec id="s3">
    <title>Introduction</title>
    <p>Since the early 1900s, various studies have reported the carcinogenic properties of
retroviruses (<xref rid="R1" ref-type="bibr">1</xref>). In the 1960s, Sir Anthony Epstein,
Bert Achong and Yvonne Barr identified the first human tumor virus in a cell culture of
samples from pediatric Burkitt’s lymphoma patients in Africa; that virus was named the
Epstein–Barr virus (EBV) (<xref rid="R2" ref-type="bibr">2</xref>). Since then, evidence of
the association between cancers and infections with certain viruses has been accumulating,
and people have identified several cancer-associated viruses, including EBV, human
papillomavirus (HPV), Kaposi’s sarcoma-associated herpesvirus (KSHV; also known as human
herpesvirus 8, HHV8), hepatitis C virus (HCV), hepatitis B virus (HBV), Merkel cell
polyomavirus (MCV) and human T-cell lymphotropic virus (HTLV) (<xref rid="R3" ref-type="bibr">3</xref>). Infection with these viruses is the etiology of approximately 15% of
all cancer cases worldwide (<xref rid="R4" ref-type="bibr">4</xref>). According to the
assessment of the International Agency for Research on Cancer (IARC), HBV and HCV are
indirect carcinogens that cause cancers by promoting a chronic inflammatory state, while
HPV, MCV, EBV, HHV8 and HTLV are direct carcinogens (<xref rid="R5" ref-type="bibr">5</xref>).</p>
    <p>HPV contains a double-stranded DNA (dsDNA) genome that is approximately 8 kbps in length
(<xref rid="R6" ref-type="bibr">6</xref>, <xref rid="R7" ref-type="bibr">7</xref>). It
causes almost all cervical, anal, genital, head and neck cancers and 30% of oropharyngeal
cancers (<xref rid="R8" ref-type="bibr">8</xref>). EBV is also a DNA virus that has a dsDNA
genome that is 175 kbps in length, and nearly 95% of healthy adults have asymptomatic
infections with EBV (<xref rid="R9" ref-type="bibr">9</xref>). The effects of EBV infection
vary by geographic location, but it mainly causes nasopharyngeal cancer (<xref rid="R10" ref-type="bibr">10</xref>), posttransplant lymphoproliferative disorders (PTLDs)
(<xref rid="R11" ref-type="bibr">11</xref>), Burkitt lymphoma (BL) (<xref rid="R12" ref-type="bibr">12</xref>) and Hodgkin lymphoma (<xref rid="R13" ref-type="bibr">13</xref>). HBV
contains a partial dsDNA genome that is approximately 3.2 kbps in length (<xref rid="R14" ref-type="bibr">14</xref>). HCV has a single-stranded RNA genome that is
approximately 9.6 kbps in length (<xref rid="R15" ref-type="bibr">15</xref>). HBV and HCV
can cause hepatitis with variable degrees of damage, which, more seriously, can lead to
cirrhosis and hepatocellular carcinoma (<xref rid="R16" ref-type="bibr">16</xref>).
Moreover, studies have shown that HCV and HBV infections cause pancreatic cancer (<xref rid="R17" ref-type="bibr">17</xref>). MCV is a DNA virus that is nearly 5.4 kbps in length
(<xref rid="R18" ref-type="bibr">18</xref>). MCV often causes a relatively harmless
infection that persists lifelong, although it can also cause serious skin cancers and Merkle
cell carcinoma (MCC) (<xref rid="R19" ref-type="bibr">19</xref>, <xref rid="R20" ref-type="bibr">20</xref>). It has also been reported that the probability of MCC in AIDS
patients is 10 times that in ordinary patients (<xref rid="R21" ref-type="bibr">21</xref>).
HTLV is approximately 9 kb in length (<xref rid="R22" ref-type="bibr">22</xref>). The
retrovirus human T-cell lymphotropic virus type 1 (HTLV-1) has infected 10–20 million
people, although most of them are asymptomatic (<xref rid="R23" ref-type="bibr">23</xref>).
Some infected patients develop highly aggressive malignancies, such as adult T-cell
leukemia/lymphoma and HTLV-1-associated myelopathy/tropical spastic palsy (<xref rid="R24" ref-type="bibr">24</xref>, <xref rid="R25" ref-type="bibr">25</xref>). KSHV,
also known as HHV8, is a DNA virus that often causes Kaposi’s sarcoma, which is a type of
skin cancer (<xref rid="R26" ref-type="bibr">26</xref>). The entire genome of HHV8 is 14
kbps in length (<xref rid="R27" ref-type="bibr">27</xref>).</p>
    <p>As research has progressed, the importance of viruses in the etiology of various cancers
has become increasingly clear, and there are already several resources that collect and host
relevant information on tumor viruses. For example, the NCBI Nucleotide database contains a
large number of viral nucleotide sequences submitted by researchers (<xref rid="R28" ref-type="bibr">28</xref>). In addition, ViPR, which is a pathogenic virus database and
analytical resource, contains more information about these viruses, including their
sequences, genes, proteins, immune epitopes and so on, and provides some basic analytical
tools, such as those for sequence alignment, phylogenetic inference and BLAST comparisons
(<xref rid="R29" ref-type="bibr">29</xref>). However, there is no resource that is focused
on cancer-associated viruses, and it is still difficult for researchers to obtain the
reference genomes. Considering that the number of cancers caused by viral infections has
increased dramatically, a complete database that could support research on the relationship
between these viruses and diseases is urgently needed. Here, we introduce iCAV, which is an
integrative database of cancer-associated viruses, with reference genomes and the related
metadata for seven types of cancer-associated viruses. To ensure convenient usage of the
database, all viruses are grouped by sample country and disease, and researchers can utilize
the browsing functions to obtain the results of interest.</p>
  </sec>
  <sec id="s4">
    <title>Materials and Methods</title>
    <sec id="s4-s1">
      <title>Data collection and processing</title>
      <p>We searched for the nucleotide sequences of all seven viruses uploaded to the NCBI
nucleotide database as of October 2020 using several carefully chosen keywords and then
downloaded them (<xref rid="T1" ref-type="table">Table 1</xref>). To obtain the complete
genome sequences, we first filtered the results by the range of genome length, which was
defined as the known approximate length, and removed the sequences that only contain a
portion of a genome (<xref rid="T1" ref-type="table">Table 1</xref>). Then, we extracted
the relevant information for each virus, including the GenBank ID, definition, strain
name, isolate name, geographic origin, sample type, and related phenotype. We also
accessed the original study in which the virus sequences were published by searching for
the PMID. For those genomes without PMIDs listed, we tried to obtain the relevant studies
based on their reference titles. And then we searched the titles in PubMed database. At
last, we took about 700 articles. All retrieved articles were carefully curated, the
missing information, including countries, samples and phenotypes, were extracted from the
original studies. The sample types were categorized by their source, such as plasma,
serum, biopsy and cell line. We also carefully determined the country of the samples where
the viruses were isolated. With regard to the phenotypes, we classified them into the
specific disease or a healthy phenotype. Individuals who did not have any specific disease
were defined as healthy (<xref rid="F1" ref-type="fig">Figure 1</xref>). At last, detailed
information, such as countries, samples and phenotypes, retrieved from NCBI nucleotide
database and NCBI PubMed database were integrated, while the genomic sequences were also
provided in iCAV (<xref rid="R30" ref-type="bibr">30</xref>).</p>
      <table-wrap position="float" id="T1">
        <label>Table 1.</label>
        <caption>
          <p>The keywords and length range of each virus</p>
        </caption>
        <table frame="hsides" rules="groups">
          <colgroup span="1">
            <col align="left" span="1"/>
            <col align="left" span="1"/>
            <col align="left" span="1"/>
          </colgroup>
          <thead>
            <tr>
              <th valign="bottom" align="left" rowspan="1" colspan="1">Virus</th>
              <th valign="bottom" align="left" rowspan="1" colspan="1">Keywords</th>
              <th valign="bottom" align="left" rowspan="1" colspan="1">Length</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" rowspan="1" colspan="1">HTLV</td>
              <td align="left" rowspan="1" colspan="1">Human T-cell lymphotropic virus OR HTLV OR Human T-lymphotropic
virus</td>
              <td align="left" rowspan="1" colspan="1">8000–10 000</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">HBV</td>
              <td align="left" rowspan="1" colspan="1">Hepatitis B virus OR HBV</td>
              <td align="left" rowspan="1" colspan="1">3000–3300</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">HCV</td>
              <td align="left" rowspan="1" colspan="1">Hepacivirus C OR HCV</td>
              <td align="left" rowspan="1" colspan="1">8900–10 000</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">MCV</td>
              <td align="left" rowspan="1" colspan="1">Merkel cell polyomavirus OR MCV OR MCPyV</td>
              <td align="left" rowspan="1" colspan="1">5000–5500</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">HPV</td>
              <td align="left" rowspan="1" colspan="1">Human papillomavirus OR HPV</td>
              <td align="left" rowspan="1" colspan="1">7000–10 000</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">HHV-8</td>
              <td align="left" rowspan="1" colspan="1">Human gammaherpesvirus 8 KSHV Kaposi’s sarcoma- associated
herpesvirus</td>
              <td align="left" rowspan="1" colspan="1">130 000–140 000</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">EBV</td>
              <td align="left" rowspan="1" colspan="1">Human herpesvirus 4 OR Human gamma- herpesvirus 4 OR EBV OR
Epstein–Barr virus</td>
              <td align="left" rowspan="1" colspan="1">160 000–180 000</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <fig position="float" id="F1" fig-type="figure">
        <label>Figure 1.</label>
        <caption>
          <p>Relationships among samples, viruses and diseases. This figure shows mainly samples
and diseases.</p>
        </caption>
        <graphic xlink:href="baab079f1" position="float"/>
      </fig>
    </sec>
    <sec id="s4-s2">
      <title>Construction of the website</title>
      <p>The data we collected are stored in a MySQL database. The website was built using HTML,
JavaScript and PHP, and several open source front-end libraries, such as jQuery and
Bootstrap, were used to further modify the website (<xref rid="R31" ref-type="bibr">31</xref>). Then, the website was hosted on an Apache server. In addition, to ensure a
smooth user experience, we tested the iCAV site on a variety of browsers, such as Google
Chrome and Internet Explorer.</p>
    </sec>
  </sec>
  <sec id="s5">
    <title>Results</title>
    <sec id="s5-s1">
      <title>Composition of the data in iCAV</title>
      <p>In total, 18 649 reference genomes of seven types of viruses were collected, including
9213 HBV genome sequences, 6622 HPV genome sequences, 1366 HCV genome sequences, 1103 EBV
genome sequences, 204 HTLV genome sequences, 75 HHV8 genome sequences and 66 MCV genome
sequences (<xref rid="F1" ref-type="fig">Figure 1</xref>). Our data were related to 87
phenotypes and 66 sample types, which originated from 143 countries worldwide, while the
data types of each virus are presented in <xref rid="F1" ref-type="fig">Figure 1</xref>,
<xref rid="T2 T3" ref-type="table">Tables 2 and 3</xref>. For example, in 9213
individuals infected with HBV, 3652 had chronic hepatitis B (CHB), 2575 were healthy, 462
had hepatitis, 175 had hepatocellular carcinoma (HCC) and 2349 had other diseases (<xref rid="T2" ref-type="table">Table 2</xref>). The sample types were 5410 serum samples, 119
blood samples, 772 plasma samples, 12 biopsy samples and 2892 other samples (<xref rid="T3" ref-type="table">Table 3</xref>). In 6622 individuals infected with HPV, 433
were healthy, 5973 had other disease, 196 had cervical cancer (CC), 19 had squamous-cell
carcinoma (SCC) and 1 had genital cancer (GC) (<xref rid="T2" ref-type="table">Table 2</xref>). The sample types were 6372 other samples, 160 biopsies, 78 cervical
swabs and 12 serum samples (<xref rid="T3" ref-type="table">Table 3</xref>).</p>
      <table-wrap position="float" id="T2">
        <label>Table 2.</label>
        <caption>
          <p>The phenotypes of each virus</p>
        </caption>
        <table frame="hsides" rules="groups">
          <colgroup span="1">
            <col align="left" span="1"/>
            <col align="left" span="1"/>
            <col align="left" span="1"/>
          </colgroup>
          <thead>
            <tr>
              <th valign="bottom" align="left" rowspan="1" colspan="1">Virus</th>
              <th valign="bottom" align="left" rowspan="1" colspan="1">Phenotypes</th>
              <th valign="bottom" align="left" rowspan="1" colspan="1">Count</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" rowspan="1" colspan="1">HBV</td>
              <td align="left" rowspan="1" colspan="1">CHB</td>
              <td align="left" rowspan="1" colspan="1">3652</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Health</td>
              <td align="left" rowspan="1" colspan="1">2575</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Hepatitis</td>
              <td align="left" rowspan="1" colspan="1">462</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">HCC</td>
              <td align="left" rowspan="1" colspan="1">175</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Other diseases</td>
              <td align="left" rowspan="1" colspan="1">2349</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">HPV</td>
              <td align="left" rowspan="1" colspan="1">CC</td>
              <td align="left" rowspan="1" colspan="1">196</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">SCC</td>
              <td align="left" rowspan="1" colspan="1">19</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">GC</td>
              <td align="left" rowspan="1" colspan="1">1</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Health</td>
              <td align="left" rowspan="1" colspan="1">433</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Other diseases</td>
              <td align="left" rowspan="1" colspan="1">5973</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">HCV</td>
              <td align="left" rowspan="1" colspan="1">Hepatitis</td>
              <td align="left" rowspan="1" colspan="1">50</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Chronic hepatitis C (CHC)</td>
              <td align="left" rowspan="1" colspan="1">45</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">HCC</td>
              <td align="left" rowspan="1" colspan="1">41</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Health</td>
              <td align="left" rowspan="1" colspan="1">794</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Other diseases</td>
              <td align="left" rowspan="1" colspan="1">436</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">EBV</td>
              <td align="left" rowspan="1" colspan="1">Nasopharyngeal cancer</td>
              <td align="left" rowspan="1" colspan="1">283</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Natural-killer/T cell lymphoma (NKTCL)</td>
              <td align="left" rowspan="1" colspan="1">53</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">GC</td>
              <td align="left" rowspan="1" colspan="1">26</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Hodgkin lymphoma</td>
              <td align="left" rowspan="1" colspan="1">16</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Lung cancer (LC)</td>
              <td align="left" rowspan="1" colspan="1">4</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Health</td>
              <td align="left" rowspan="1" colspan="1">213</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">HTLV</td>
              <td align="left" rowspan="1" colspan="1">HTLV-1-associated myelopathy/tropical spastic palsy</td>
              <td align="left" rowspan="1" colspan="1">78</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Health</td>
              <td align="left" rowspan="1" colspan="1">59</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Adult T-cell leukemia-lymphoma (ATLL)</td>
              <td align="left" rowspan="1" colspan="1">16</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Other diseases</td>
              <td align="left" rowspan="1" colspan="1">51</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">HHV8</td>
              <td align="left" rowspan="1" colspan="1">Kaposi’s sarcoma (KS)</td>
              <td align="left" rowspan="1" colspan="1">19</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Primary effusion lymphoma (PEL)</td>
              <td align="left" rowspan="1" colspan="1">3</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Multicentric castleman disease (MCD)</td>
              <td align="left" rowspan="1" colspan="1">3</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Other diseases</td>
              <td align="left" rowspan="1" colspan="1">50</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">MCV</td>
              <td align="left" rowspan="1" colspan="1">MCC</td>
              <td align="left" rowspan="1" colspan="1">28</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Other diseases</td>
              <td align="left" rowspan="1" colspan="1">5</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Health</td>
              <td align="left" rowspan="1" colspan="1">33</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <table-wrap position="float" id="T3">
        <label>Table 3.</label>
        <caption>
          <p>The samples of each virus</p>
        </caption>
        <table frame="hsides" rules="groups">
          <colgroup span="1">
            <col align="left" span="1"/>
            <col align="left" span="1"/>
            <col align="left" span="1"/>
          </colgroup>
          <thead>
            <tr>
              <th valign="bottom" align="left" rowspan="1" colspan="1">Virus</th>
              <th valign="bottom" align="left" rowspan="1" colspan="1">Samples</th>
              <th valign="bottom" align="left" rowspan="1" colspan="1">Count</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" rowspan="1" colspan="1">HBV</td>
              <td align="left" rowspan="1" colspan="1">Serum</td>
              <td align="left" rowspan="1" colspan="1">5410</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Blood</td>
              <td align="left" rowspan="1" colspan="1">119</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Plasma</td>
              <td align="left" rowspan="1" colspan="1">772</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Biopsy</td>
              <td align="left" rowspan="1" colspan="1">12</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Other samples</td>
              <td align="left" rowspan="1" colspan="1">2892</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">HPV</td>
              <td align="left" rowspan="1" colspan="1">Biopsy</td>
              <td align="left" rowspan="1" colspan="1">160</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Other samples</td>
              <td align="left" rowspan="1" colspan="1">6372</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Cervical swab</td>
              <td align="left" rowspan="1" colspan="1">78</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Serum</td>
              <td align="left" rowspan="1" colspan="1">12</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">HCV</td>
              <td align="left" rowspan="1" colspan="1">Plasma</td>
              <td align="left" rowspan="1" colspan="1">677</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Serum</td>
              <td align="left" rowspan="1" colspan="1">434</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Cell lines</td>
              <td align="left" rowspan="1" colspan="1">10</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Other samples</td>
              <td align="left" rowspan="1" colspan="1">245</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">EBV</td>
              <td align="left" rowspan="1" colspan="1">Saliva</td>
              <td align="left" rowspan="1" colspan="1">291</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Other samples</td>
              <td align="left" rowspan="1" colspan="1">371</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Biopsy</td>
              <td align="left" rowspan="1" colspan="1">284</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Plasma</td>
              <td align="left" rowspan="1" colspan="1">1</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Cell line</td>
              <td align="left" rowspan="1" colspan="1">156</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">HTLV</td>
              <td align="left" rowspan="1" colspan="1">Peripheral blood mononuclear cell (PBMC)</td>
              <td align="left" rowspan="1" colspan="1">106</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Other samples</td>
              <td align="left" rowspan="1" colspan="1">52</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Blood</td>
              <td align="left" rowspan="1" colspan="1">45</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Plasma</td>
              <td align="left" rowspan="1" colspan="1">1</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">HHV8</td>
              <td align="left" rowspan="1" colspan="1">Other samples</td>
              <td align="left" rowspan="1" colspan="1">56</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Biopsy</td>
              <td align="left" rowspan="1" colspan="1">16</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Cell line</td>
              <td align="left" rowspan="1" colspan="1">3</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">MCV</td>
              <td align="left" rowspan="1" colspan="1">Other samples</td>
              <td align="left" rowspan="1" colspan="1">54</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">PBMC</td>
              <td align="left" rowspan="1" colspan="1">5</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Biopsy</td>
              <td align="left" rowspan="1" colspan="1">5</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Cell line</td>
              <td align="left" rowspan="1" colspan="1">1</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Serum</td>
              <td align="left" rowspan="1" colspan="1">1</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
    </sec>
    <sec id="s5-s2">
      <title>Usage and presentation in iCAV</title>
      <p>All data were classified by virus type, so it is convenient for users to access the
corresponding records and relevant information for each type of virus (<xref rid="F2" ref-type="fig">Figure 2A</xref>). We also listed the sample, country and
disease on the left, which allows users to further filter the results (<xref rid="F2" ref-type="fig">Figure 2B</xref>). After accessing the viruses of interest,
users can download the genome sequences in FASTA format and the metadata (<xref rid="F2" ref-type="fig">Figure 2C</xref>). Detailed information on the virus is provided
if they click the ‘More’ link, including the GenBank ID, strain name, isolate name,
definition, resource, sample, country and disease (<xref rid="F2" ref-type="fig">Figure 2C–D</xref>). The complete genome sequence is also displayed (<xref rid="F2" ref-type="fig">Figure 2E</xref>), and users can download it separately.
Moreover, users can obtain all the data for their further analysis in the download page.
We guarantee that we will not record any information about our visitors, including IP,
private information and browsing histories.</p>
      <fig position="float" id="F2" fig-type="figure">
        <label>Figure 2.</label>
        <caption>
          <p>The usage of iCAV. (A–E) Five steps to use iCAV.</p>
        </caption>
        <graphic xlink:href="baab079f2" position="float"/>
      </fig>
    </sec>
  </sec>
  <sec id="s6">
    <title>Discussion</title>
    <p>These seven types of viruses, including EBV, HCV, HBV, HTLV, HHV8 and HPV, have been
defined as Group 1 human carcinogens by the IARC, and MCV is classified as Group 2A (<xref rid="R32" ref-type="bibr">32</xref>). Among all cases of cancer caused by viral
infections, the vast majority (&gt;85%) occur in developing countries (<xref rid="R33" ref-type="bibr">33</xref>). Therefore, there is a growing urgency to study the relationship
between viruses and cancers.</p>
    <p>iCAV is the first database focused on cancer-associated viruses, and it provides users with
the genome sequences and related phenotypes for seven human tumor viruses. By carefully
collecting and integrating the metadata, iCAV can provide detailed information about the
relationships between viruses and diseases that is easy for users to access. Our website
provides a simple and straightforward interface for users to browse for the viruses of
interest, and the results are clearly displayed and can be downloaded. In conclusion, iCAV
is a convenient resource for researchers studying the relationships between virus genomic
sequences and diseases and can improve research efficiency.</p>
    <p>In this study, we collected the full and nearly full genome sequences of seven types of
human cancer-associated viruses. The NCBI nucleotide database provides detailed sequence
information, but the phenotypic information is missing. Therefore, we developed the iCAV
database, which provides detailed phenotypic information to help us sort through large
amounts of data to find the relevant information. Our goal is to integrate the available
information about viruses and phenotypes. In the future, iCAV will be regularly maintained
and updated every 2 years through surveying the lasted virus data of complete genome to
provide more detailed and comprehensive information. We anticipate that the iCAV database
will facilitate subsequent analyses by other researchers.</p>
  </sec>
</body>
<back>
  <sec id="s7">
    <title>Funding</title>
    <p>Natural Science Foundation of China (81972239 and 91953123 to Z.-X.L., 31601067 to H.C.),
Fostering Fund of Fundamental Research for Young Teachers of Zhengzhou University
(JC21343016 to H.C.), Program for Guangdong Introducing Innovative and Entrepreneurial Teams
(2017ZT07S096 to Z.-X.L.), Guangdong Esophageal Cancer Institute Science and Technology
Program (M201911 to Z.-X.L.) and Tip-Top Scientific and Technical Innovative Youth Talents
of Guangdong special support program (2019TQ05Y351 to Z.-X.L.).</p>
  </sec>
  <sec id="s8">
    <title>Conflict of interest</title>
    <p>The authors declare no conflict of interest.</p>
  </sec>
  <ref-list id="ref1">
    <title>References</title>
    <ref id="R1">
      <label>1.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gaglia</surname><given-names>M.M.</given-names></string-name> and
<string-name><surname>Munger</surname><given-names>K.</given-names></string-name></person-group>
(<year>2018</year>) <article-title>More than just oncogenes: mechanisms of tumorigenesis
by human viruses</article-title>. <source><italic toggle="yes">Curr. Opin. Virol.</italic></source>,
<volume>32</volume>, <fpage>48</fpage>–<lpage>59</lpage>.<pub-id pub-id-type="pmid">30268926</pub-id></mixed-citation>
    </ref>
    <ref id="R2">
      <label>2.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Epstein</surname><given-names>M.A.</given-names></string-name>,
<string-name><surname>Achong</surname><given-names>B.G.</given-names></string-name>
and
<string-name><surname>Barr</surname><given-names>Y.M.</given-names></string-name></person-group>
(<year>1964</year>) <article-title>Virus particles in cultured lymphoblasts from
Burkitt’s lymphoma</article-title>. <source><italic toggle="yes">Lancet</italic></source>,
<volume>1</volume>, <fpage>702</fpage>–<lpage>703</lpage>.<pub-id pub-id-type="pmid">14107961</pub-id></mixed-citation>
    </ref>
    <ref id="R3">
      <label>3.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Moore</surname><given-names>P.S.</given-names></string-name> and
<string-name><surname>Chang</surname><given-names>Y.</given-names></string-name></person-group>
(<year>2010</year>) <article-title>Why do viruses cause cancer? Highlights of the first
century of human tumour virology</article-title>. <source><italic toggle="yes">Nat. Rev.
Cancer</italic></source>, <volume>10</volume>,
<fpage>878</fpage>–<lpage>889</lpage>.<pub-id pub-id-type="pmid">21102637</pub-id></mixed-citation>
    </ref>
    <ref id="R4">
      <label>4.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Martin</surname><given-names>D.</given-names></string-name> and
<string-name><surname>Gutkind</surname><given-names>J.S.</given-names></string-name></person-group>
(<year>2008</year>) <article-title>Human tumor-associated viruses and new insights into
the molecular mechanisms of cancer</article-title>.
<source><italic toggle="yes">Oncogene</italic></source>, <volume>27</volume>,
<fpage>S31</fpage>–<lpage>S42</lpage>.<pub-id pub-id-type="pmid">19956178</pub-id></mixed-citation>
    </ref>
    <ref id="R5">
      <label>5.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname><given-names>C.J.</given-names></string-name>,
<string-name><surname>Hsu</surname><given-names>W.L.</given-names></string-name>,
<string-name><surname>Yang</surname><given-names>H.I.</given-names></string-name></person-group><etal>et al.</etal> (<year>2014</year>) <article-title>Epidemiology of virus infection and
human cancer</article-title>. <source><italic toggle="yes">Recent Results Cancer
Res.</italic></source>, <volume>193</volume>,
<fpage>11</fpage>–<lpage>32</lpage>.<pub-id pub-id-type="pmid">24008291</pub-id></mixed-citation>
    </ref>
    <ref id="R6">
      <label>6.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Graham</surname><given-names>S.V.</given-names></string-name></person-group> (<year>2017</year>) <article-title>The human papillomavirus replication
cycle, and its links to cancer progression: a comprehensive review</article-title>.
<source><italic toggle="yes">Clin. Sci.</italic></source>, <volume>131</volume>,
<fpage>2201</fpage>–<lpage>2221</lpage>.</mixed-citation>
    </ref>
    <ref id="R7">
      <label>7.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Scheurer</surname><given-names>M.E.</given-names></string-name>,
<string-name><surname>Tortolero-Luna</surname><given-names>G.</given-names></string-name>
and
<string-name><surname>Adler-Storthz</surname><given-names>K.</given-names></string-name></person-group>
(<year>2005</year>) <article-title>Human papillomavirus infection: biology,
epidemiology, and prevention</article-title>. <source><italic toggle="yes">Int. J. Gynecol.
Cancer</italic></source>, <volume>15</volume>,
<fpage>727</fpage>–<lpage>746</lpage>.<pub-id pub-id-type="pmid">16174218</pub-id></mixed-citation>
    </ref>
    <ref id="R8">
      <label>8.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Szymonowicz</surname><given-names>K.A.</given-names></string-name> and
<string-name><surname>Chen</surname><given-names>J.</given-names></string-name></person-group>
(<year>2020</year>) <article-title>Biological and clinical aspects of HPV-related
cancers</article-title>. <source><italic toggle="yes">Cancer Biol. Med.</italic></source>,
<volume>17</volume>, <fpage>864</fpage>–<lpage>878</lpage>.<pub-id pub-id-type="pmid">33299640</pub-id></mixed-citation>
    </ref>
    <ref id="R9">
      <label>9.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kanda</surname><given-names>T.</given-names></string-name>,
<string-name><surname>Yajima</surname><given-names>M.</given-names></string-name> and
<string-name><surname>Ikuta</surname><given-names>K.</given-names></string-name></person-group>
(<year>2019</year>) <article-title>Epstein-Barr virus strain variation and
cancer</article-title>. <source><italic toggle="yes">Cancer Sci.</italic></source>,
<volume>110</volume>, <fpage>1132</fpage>–<lpage>1139</lpage>.<pub-id pub-id-type="pmid">30697862</pub-id></mixed-citation>
    </ref>
    <ref id="R10">
      <label>10.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Teow</surname><given-names>S.Y.</given-names></string-name>,
<string-name><surname>Yap</surname><given-names>H.Y.</given-names></string-name> and
<string-name><surname>Peh</surname><given-names>S.C.</given-names></string-name></person-group>
(<year>2017</year>) <article-title>Epstein-barr virus as a promising immunotherapeutic
target for nasopharyngeal carcinoma treatment</article-title>. <source><italic toggle="yes">J.
Pathog.</italic></source>,
<volume>2017</volume>,<page-range>7349268</page-range>.</mixed-citation>
    </ref>
    <ref id="R11">
      <label>11.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dharnidharka</surname><given-names>V.R.</given-names></string-name>,
<string-name><surname>Webster</surname><given-names>A.C.</given-names></string-name>,
<string-name><surname>Martinez</surname><given-names>O.M.</given-names></string-name></person-group><etal>et al.</etal> (<year>2016</year>) <article-title>Post-transplant lymphoproliferative
disorders</article-title>. <source><italic toggle="yes">Nat. Rev. Dis. Primers</italic></source>,
<volume>2</volume>, <page-range>15088</page-range>.</mixed-citation>
    </ref>
    <ref id="R12">
      <label>12.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rochford</surname><given-names>R.</given-names></string-name> and
<string-name><surname>Moormann</surname><given-names>A.M.</given-names></string-name></person-group>
(<year>2015</year>) <article-title>Burkitt’s lymphoma</article-title>.
<source><italic toggle="yes">Curr. Top. Microbiol. Immunol.</italic></source>,
<volume>390</volume>, <fpage>267</fpage>–<lpage>285</lpage>.<pub-id pub-id-type="pmid">26424650</pub-id></mixed-citation>
    </ref>
    <ref id="R13">
      <label>13.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Farrell</surname><given-names>K.</given-names></string-name> and
<string-name><surname>Jarrett</surname><given-names>R.F.</given-names></string-name></person-group>
(<year>2011</year>) <article-title>The molecular pathogenesis of Hodgkin
lymphoma</article-title>. <source><italic toggle="yes">Histopathology</italic></source>,
<volume>58</volume>, <fpage>15</fpage>–<lpage>25</lpage>.<pub-id pub-id-type="pmid">21261680</pub-id></mixed-citation>
    </ref>
    <ref id="R14">
      <label>14.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Herrscher</surname><given-names>C.</given-names></string-name>,
<string-name><surname>Roingeard</surname><given-names>P.</given-names></string-name>
and
<string-name><surname>Blanchard</surname><given-names>E.</given-names></string-name></person-group>
(<year>2020</year>) <article-title>Hepatitis B virus entry into cells</article-title>.
<source><italic toggle="yes">Cells</italic></source>, <volume>9</volume>, 1486.doi: <pub-id pub-id-type="doi">10.3390/cells9061486</pub-id>.</mixed-citation>
    </ref>
    <ref id="R15">
      <label>15.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname><given-names>M.</given-names></string-name>,
<string-name><surname>Ma</surname><given-names>Y.</given-names></string-name>,
<string-name><surname>Chen</surname><given-names>H.</given-names></string-name></person-group><etal>et al.</etal> (<year>2019</year>) <article-title>Complete genome sequencing and
evolutionary analysis of HCV subtype 6xg from IDUs in Yunnan, China</article-title>.
<source><italic toggle="yes">PLoS One</italic></source>, <volume>14</volume>,
<page-range>e0217010</page-range>.</mixed-citation>
    </ref>
    <ref id="R16">
      <label>16.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dandri</surname><given-names>M.</given-names></string-name> and
<string-name><surname>Locarnini</surname><given-names>S.</given-names></string-name></person-group>
(<year>2012</year>) <article-title>New insight in the pathobiology of hepatitis B virus
infection</article-title>. <source><italic toggle="yes">Gut</italic></source>, <volume>61</volume>,
<fpage>i6</fpage>–<lpage>i17</lpage>.<pub-id pub-id-type="pmid">22504921</pub-id></mixed-citation>
    </ref>
    <ref id="R17">
      <label>17.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fiorino</surname><given-names>S.</given-names></string-name>,
<string-name><surname>Cuppini</surname><given-names>A.</given-names></string-name>,
<string-name><surname>Castellani</surname><given-names>G.</given-names></string-name></person-group><etal>et al.</etal> (<year>2013</year>) <article-title>HBV- and HCV-related infections and
risk of pancreatic cancer</article-title>. <source><italic toggle="yes">JOP J.
Pancreas</italic></source>, <volume>14</volume>,
<fpage>603</fpage>–<lpage>609</lpage>.</mixed-citation>
    </ref>
    <ref id="R18">
      <label>18.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shuda</surname><given-names>M.</given-names></string-name>,
<string-name><surname>Arora</surname><given-names>R.</given-names></string-name>,
<string-name><surname>Kwun</surname><given-names>H.J.</given-names></string-name></person-group><etal>et al.</etal> (<year>2009</year>) <article-title>Human Merkel cell polyomavirus
infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and
lymphoid tumors</article-title>. <source><italic toggle="yes">Int. J. Cancer</italic></source>,
<volume>125</volume>, <fpage>1243</fpage>–<lpage>1249</lpage>.<pub-id pub-id-type="pmid">19499546</pub-id></mixed-citation>
    </ref>
    <ref id="R19">
      <label>19.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>DeCaprio</surname><given-names>J.A.</given-names></string-name></person-group> (<year>2017</year>) <article-title>Merkel cell polyomavirus and Merkel
cell carcinoma</article-title>. <source><italic toggle="yes">Philos. Trans. R. Soc. Lond., B, Biol.
Sci.</italic></source>, <volume>372</volume>,
<page-range>1732</page-range>.</mixed-citation>
    </ref>
    <ref id="R20">
      <label>20.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Buck</surname><given-names>C.B.</given-names></string-name>, <string-name><surname>Van
Doorslaer</surname><given-names>K.</given-names></string-name>,
<string-name><surname>Peretti</surname><given-names>A.</given-names></string-name></person-group><etal>et al.</etal> (<year>2016</year>) <article-title>The ancient evolutionary history of
polyomaviruses</article-title>. <source><italic toggle="yes">PLoS Pathog.</italic></source>,
<volume>12</volume>, <page-range>e1005574</page-range>.</mixed-citation>
    </ref>
    <ref id="R21">
      <label>21.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Engels</surname><given-names>E.A.</given-names></string-name>,
<string-name><surname>Frisch</surname><given-names>M.</given-names></string-name>,
<string-name><surname>Goedert</surname><given-names>J.J.</given-names></string-name></person-group><etal>et al.</etal> (<year>2002</year>) <article-title>Merkel cell carcinoma and HIV
infection</article-title>. <source><italic toggle="yes">Lancet</italic></source>,
<volume>359</volume>, <fpage>497</fpage>–<lpage>498</lpage>.<pub-id pub-id-type="pmid">11853800</pub-id></mixed-citation>
    </ref>
    <ref id="R22">
      <label>22.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Martinez</surname><given-names>M.P.</given-names></string-name>,
<string-name><surname>Al-Saleem</surname><given-names>J.</given-names></string-name>
and
<string-name><surname>Green</surname><given-names>P.L.</given-names></string-name></person-group>
(<year>2019</year>) <article-title>Comparative virology of HTLV-1 and
HTLV-2</article-title>. <source><italic toggle="yes">Retrovirology</italic></source>,
<volume>16</volume>, <page-range>21</page-range>.</mixed-citation>
    </ref>
    <ref id="R23">
      <label>23.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gessain</surname><given-names>A.</given-names></string-name> and
<string-name><surname>Cassar</surname><given-names>O.</given-names></string-name></person-group>
(<year>2012</year>) <article-title>Epidemiological Aspects and World Distribution of
HTLV-1 Infection</article-title>. <source><italic toggle="yes">Front Microbiol.</italic></source>,
<volume>3</volume>, <page-range>388</page-range>.</mixed-citation>
    </ref>
    <ref id="R24">
      <label>24.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Taylor</surname><given-names>G.P.</given-names></string-name> and
<string-name><surname>Matsuoka</surname><given-names>M.</given-names></string-name></person-group>
(<year>2005</year>) <article-title>Natural history of adult T-cell leukemia/lymphoma and
approaches to therapy</article-title>. <source><italic toggle="yes">Oncogene</italic></source>,
<volume>24</volume>, <fpage>6047</fpage>–<lpage>6057</lpage>.<pub-id pub-id-type="pmid">16155611</pub-id></mixed-citation>
    </ref>
    <ref id="R25">
      <label>25.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Matsuoka</surname><given-names>M.</given-names></string-name> and
<string-name><surname>Jeang</surname><given-names>K.T.</given-names></string-name></person-group>
(<year>2007</year>) <article-title>Human T-cell leukaemia virus type 1 (HTLV-1)
infectivity and cellular transformation</article-title>. <source><italic toggle="yes">Nat. Rev.
Cancer</italic></source>, <volume>7</volume>,
<fpage>270</fpage>–<lpage>280</lpage>.<pub-id pub-id-type="pmid">17384582</pub-id></mixed-citation>
    </ref>
    <ref id="R26">
      <label>26.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chang</surname><given-names>Y.</given-names></string-name>,
<string-name><surname>Cesarman</surname><given-names>E.</given-names></string-name>,
<string-name><surname>Pessin</surname><given-names>M.S.</given-names></string-name></person-group><etal>et al.</etal> (<year>1994</year>) <article-title>Identification of herpesvirus-like
DNA sequences in AIDS-associated Kaposi’s sarcoma</article-title>.
<source><italic toggle="yes">Science</italic></source>, <volume>266</volume>,
<fpage>1865</fpage>–<lpage>1869</lpage>.<pub-id pub-id-type="pmid">7997879</pub-id></mixed-citation>
    </ref>
    <ref id="R27">
      <label>27.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Olp</surname><given-names>L.N.</given-names></string-name>,
<string-name><surname>Jeanniard</surname><given-names>A.</given-names></string-name>,
<string-name><surname>Marimo</surname><given-names>C.</given-names></string-name></person-group><etal>et al.</etal> (<year>2015</year>) <article-title>Whole-genome sequencing of Kaposi’s
sarcoma-associated herpesvirus from Zambian Kaposi’s sarcoma biopsy specimens reveals
unique viral diversity</article-title>. <source><italic toggle="yes">J. Virol.</italic></source>,
<volume>89</volume>, <fpage>12299</fpage>–<lpage>12308</lpage>.<pub-id pub-id-type="pmid">26423952</pub-id></mixed-citation>
    </ref>
    <ref id="R28">
      <label>28.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sayers</surname><given-names>E.W.</given-names></string-name>,
<string-name><surname>Cavanaugh</surname><given-names>M.</given-names></string-name>,
<string-name><surname>Clark</surname><given-names>K.</given-names></string-name></person-group><etal>et al.</etal> (<year>2019</year>) <article-title>GenBank</article-title>.
<source><italic toggle="yes">Nucleic Acids Res.</italic></source>, <volume>47</volume>,
<fpage>D94</fpage>–<lpage>D99</lpage>.<pub-id pub-id-type="pmid">30365038</pub-id></mixed-citation>
    </ref>
    <ref id="R29">
      <label>29.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pickett</surname><given-names>B.E.</given-names></string-name>,
<string-name><surname>Sadat</surname><given-names>E.L.</given-names></string-name>,
<string-name><surname>Zhang</surname><given-names>Y.</given-names></string-name></person-group><etal>et al.</etal> (<year>2012</year>) <article-title>ViPR: an open bioinformatics
database and analysis resource for virology research</article-title>.
<source><italic toggle="yes">Nucleic Acids Res.</italic></source>, <volume>40</volume>,
<fpage>D593</fpage>–<lpage>D598</lpage>.<pub-id pub-id-type="pmid">22006842</pub-id></mixed-citation>
    </ref>
    <ref id="R30">
      <label>30.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ullah</surname><given-names>S.</given-names></string-name>,
<string-name><surname>Lin</surname><given-names>S.</given-names></string-name>,
<string-name><surname>Xu</surname><given-names>Y.</given-names></string-name></person-group><etal>et al.</etal> (<year>2016</year>) <article-title>dbPAF: an integrative database of
protein phosphorylation in animals and fungi</article-title>. <source><italic toggle="yes">Sci.
Rep.</italic></source>, <volume>6</volume>,
<page-range>23534</page-range>.</mixed-citation>
    </ref>
    <ref id="R31">
      <label>31.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ullah</surname><given-names>S.</given-names></string-name>,
<string-name><surname>Ullah</surname><given-names>A.</given-names></string-name>,
<string-name><surname>Rahman</surname><given-names>W.</given-names></string-name></person-group><etal>et al.</etal> (<year>2021</year>) <article-title>An innovative user-friendly
platform for Covid-19 pandemic databases and resources</article-title>.
<source><italic toggle="yes">Comput. Methods Programs Biomed. Update</italic></source>,
<volume>1</volume>, <page-range>100031</page-range>.</mixed-citation>
    </ref>
    <ref id="R32">
      <label>32.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hatano</surname><given-names>Y.</given-names></string-name>,
<string-name><surname>Ideta</surname><given-names>T.</given-names></string-name>,
<string-name><surname>Hirata</surname><given-names>A.</given-names></string-name></person-group><etal>et al.</etal> (<year>2021</year>) <article-title>Virus-driven
carcinogenesis</article-title>. <source><italic toggle="yes">Cancers (Basel)</italic></source>,
<volume>13</volume>, 2625.doi: <pub-id pub-id-type="doi">10.3390/cancers13112625</pub-id>.</mixed-citation>
    </ref>
    <ref id="R33">
      <label>33.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schiller</surname><given-names>J.T.</given-names></string-name> and
<string-name><surname>Lowy</surname><given-names>D.R.</given-names></string-name></person-group>
(<year>2014</year>) <article-title>Virus infection and human cancer: an
overview</article-title>. <source><italic toggle="yes">Recent Results Cancer Res.</italic></source>,
<volume>193</volume>, <fpage>1</fpage>–<lpage>10</lpage>.<pub-id pub-id-type="pmid">24008290</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
